Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques
2009 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques
Schulte, R.; Suh, Y.-S.; Sauermann, U.; Ochieng, W.; Sopper, S.; Kim, K. S. & Ahn, S.-S. et al. (2009)
Virology, 383(2) pp. 300-309. DOI: https://doi.org/10.1016/j.virol.2008.10.012
